Patents

Possessing a keen understanding of and knowledge in the science and technology sectors, IPLL provides clients counseling in all advanced areas of technology. Our patent law-related services are cutting-edge, and our understanding of technology matters is unsurpassed. Our patent expertise includes patent searching; drafting and filing; prosecution; infringement, validity and freedom-to-operate analyses and opinions; due diligence investigations and analytical reviews; Post Grant Proceedings; conducting complex IP audits; establishing in-house patent




Pharmaceuticals

IPLL provides guidance and legal advice to pharmaceutical, biotechnology, and medical device companies on matters at the intersection of FDA regulation and intellectual property. Our attorneys have extensive experience in advising companies on market protection strategies, data exclusivity, patent term restoration, transactions, licensing, and due diligence. We also provide advice in these subsections: • Agrochemicals • Biodefense • Biologics and Biosimilars • Bioprocessing and Biofuels • Chemical • Life Science




Nanotechnology

Nanotechnology is the engineering of functional systems at the molecular scale, a technology based upon recognized scientific disciplines and material science fabrication techniques where individual molecules and even atoms can be arranged into precise structures. As a field and area for product development, nanotechnology includes numerous scientific disciplines, including microfabrication, molecular biology, organic chemistry, semiconductor physics and surface science. As the technology may be used to generate new materials and




Medical Devices and Instrumentation

Integration of smart technologies including engineering, biology, nanotechnology in medical device product development continues to accelerate and revolutionize medical treatments. In a fast growing industry, a comprehensive intellectual property strategy is critical for players in the medical device sector. IPLL’s qualified attorneys combine their scientific prowess and their legal expertise to advise medical devices companies on issues involving corporate governance and formation, mergers and acquisitions, public offerings, public and private




Financial Services

IPLL offers financial services effectively and efficiently in the most significant matters affecting financial institutions. While IPLL’s coverage is broad, key industry counseling areas include: regulatory initiatives and legislation; asset management; Bank Secrecy Act and OFAC; capital market activities; capital-related issues; derivatives and innovative financial products; mergers and acquisitions; privacy law compliance; private label programs; product development and compliance; regulatory enforcement defense and internal investigation. Exemplary areas of counseling include




Electronic and Information Technology

Intellectual property portfolio development and enforcement are key in today’s dynamic business environment fueled by rapid advancements in the electronics industry. IPLL helps clients to achieve the optimal use of IP for their business objectives by offering advice on management, creating enforcement-ready portfolios, negotiating licensing deals, performing IP due diligence for investment and acquisition opportunities and defending or enforcing clients’ intellectual property rights. We cover these areas of the electronics




Intellectual Property

IPLL’s intellectual property practice area includes attorneys and legal assistants with multiple decades of IP experience who have distinguished themselves in the profession. Holding advanced degrees and bringing years of industry experience in cutting-edge scientific disciplines, our counsel have represented clients throughout the world in IP procurement, prosecution, registration, licensing, technology transfer and litigation. As counsel, we are partners with high technology, life sciences and media corporations to secure and




America Invents Act Creates a Transitional Program for Covered Business Method Patents

The America Invents Act (AIA) creates new administrative trial procedures to challenge patentability outside litigation before a district court venue. These trial procedures are namely (1) Post Grant Review (PGR), (2) Inter Partes Review (IPR) and (3) a transitional program for covered business method (CBM) patents. These laws went into effect on September 16, 2012. This update covers the transitional program for covered business method patents. A specific post-grant review




The U.S. Becomes First-to-File For Patents

On September 16, 2011, President Obama signed the America Invents Act (AIA). Along with other significant changes to the U.S. patent system, this legislation converts the “first to invent” system to a “first inventor to file” system. These provisions of the Act went into effect on March 16, 2013. The new first-inventor-to-file” (FITF) system is a hybrid of the first-to-invent system preceding the Act and an actual first-to-file system, where